Autosomal Dominant Polycystic Kidney Disease (ADPKD): Treatment Targets and Options
Autosomal Dominant Polycystic Kidney Disease (ADPKD): Treatment Targets and Options is organized by National Kidney Foundation (NKF).
Available From: 7/27/2023
Available From: 7/27/2024
Course Description:
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and the most common form of PKD. Characterized by uncontrolled proliferation of renal epithelial cells leading to development and expansion of multiple cysts scattered throughout the kidney parenchyma, ADPKD causes progressive and irreversible loss of kidney function over time. Increasing investigations of pharmacologic treatments for ADPKD, and the evidence supporting treatment benefit to patients with rapidly-progressing disease, are pushing disease knowledge forward. But issues continue around the relevant alignment of staging systems with clinical manifestations, effectiveness of a treatment plan and diet for any patient, and the benefits of treatment versus transplant. This symposium will be presented as a panel discussion, where expert faculty and an ADPKD patient will present and discuss today’s current challenges in optimal patient care.
Learning Objectives:
• Compare approaches to stratify risk of rapidly-progressing disease in ADPKD patients
• Define targets and goals of treatment in ADPKD, and how to adjust them to meet individual patient needs
• Describe current barriers to optimal care for patients with ADPKD and how they may be overcome in clinical practice
Additional details will be posted as soon as information is available